Skip to the page

Data / Medical devices / United States / Pillar Biosciences

Pillar Biosciences: FDA-registered device maker in Natick, MA, United States, 1 PMA approval

Pillar Biosciences is registered with the FDA (registration 3020703032) in Natick, MA, United States. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated July 30, 2021. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3020703032
FEI number
3016560486
Address
9 Strathmore Road, Natick, MA, United States, 01760
Owner or operator
Pillar Biosciences (10082584)
Roles
Complaint file establishment, Manufacturer
First device listed
August 19, 2021
Registered through
2026
Brand names listed
PiVAT Software, oncoReveal CDx, oncoReveal CDx Box 1, oncoReveal CDx Box 2, oncoReveal CDx Box 3, oncoReveal CDx Box 4

Devices it lists

DeviceProduct codeClassRoleSource
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection SystemPQP3Complaint file establishment, Manufactureraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
July 30, 2021P200011ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA)PQP2September 27, 2024accessdata.fda.gov

Compare with other makers

Updated September 27, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.